Abstract
Susanne Cabrera, Ingrid Libman, Mustafa Tosur, Alejandro F. Siller, Kevan C. Herold, Heba M. Ismail
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
2024
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
10.1007/s00125-017-4384-2 · 2017
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
10.1001/jama.2013.6285 · 2013
Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report
10.2337/dc18-2282 · 2019
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
10.2337/dc15-1419 · 2015
Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study
10.2337/dc21-2612 · 2022
Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study
10.2337/dc16-0181 · 2016
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
10.1056/nejmoa1902226 · 2019
Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves β-cell function
10.2337/dc23-0675 · 2023
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
10.1056/nejmoa2308743 · 2023
Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY study
10.2337/dc21-0422 · 2022
Factors associated with diabetic ketoacidosis at onset of type 1 diabetes among pediatric patients: a systematic review
10.1001/jamapediatrics.2022.3586 · 2022
Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative
10.2337/cd21-0028 · 2021
A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison
10.2337/dc20-0257 · 2021
Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002–2015
10.15585/mmwr.mm6906a3 · 2020
Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the International Diabetes Federation Atlas, 11th edition, and the T1D Index version 3.0
10.1016/j.diabres.2025.112277 · 2025
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia
10.1210/jc.2010-0293 · 2010
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
10.1007/s00125-023-05877-9 · 2023
Comparative analysis of the sensitivity, specificity, concordance, and 5-year predictive power of diabetes-related autoantibody assays
10.2337/db24-0814 · 2025
Race and genetic ancestry in medicine — a time for reckoning with racism
10.1056/nejmms2029562 · 2021
Making neighborhood-disadvantage metrics accessible — The Neighborhood Atlas
10.1056/nejmp1802313 · 2018
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Contrasting adult and pediatric populations in a cohort of at-risk relatives in the T1D TrialNet Pathway to Prevention study
10.2337/dc25-0192 · 2025
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
10.1056/nejmoa1610187 · 2017
Who is enrolling? The path to monitoring in type 1 diabetes TrialNet’s Pathway to Prevention
10.2337/dc19-0593 · 2019
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
10.1001/jama.2014.3201 · 2014
Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk
10.1007/s00125-018-4660-9 · 2018
Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: a cross-sectional multicenter DPV analysis
10.2337/dc18-0724 · 2018
Regional deprivation and diabetic ketoacidosis at type 1 diabetes diagnosis in children and adolescents: international comparison among 6 countries
10.1159/000543139 · 2026
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
10.1016/s0140-6736(23)00457-9 · 2023
Type 1 diabetes incidence in Scotland between 2006 and 2019
10.1111/dme.15069 · 2023
Social determinants of health and diabetes: a scientific review
10.2337/dci20-0053 · 2020
Genetics of type 1 diabetes
10.1111/pedi.12597 · 2018
Letter: HL-A antigens and diabetes mellitus
10.1016/s0140-6736(74)90930-1 · 1974
A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk
10.2337/dc18-0087 · 2018
Chapter 13: mining electronic health records in the genomics era
10.1371/journal.pcbi.1002823 · 2012
Genetic consequences of the transatlantic slave trade in the Americas
10.1016/j.ajhg.2020.06.012 · 2020
The genetic ancestry of African Americans, Latinos, and European Americans across the United States
10.1016/j.ajhg.2014.11.010 · 2015
No additional external references are available.